Literature DB >> 28677559

Making precision oncology the standard of care.

.   

Abstract

Mesh:

Substances:

Year:  2017        PMID: 28677559     DOI: 10.1016/S1470-2045(17)30474-6

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  4 in total

1.  From the Broad Phase II Trial to Precision Oncology: A Perspective on the Origins of Basket and Umbrella Clinical Trial Designs in Cancer Drug Development.

Authors:  Deborah B Doroshow; James H Doroshow
Journal:  Cancer J       Date:  2019 Jul/Aug       Impact factor: 3.360

Review 2.  Investigating acceptability of a training programme in precision medicine for frontline healthcare professionals: a mixed methods study.

Authors:  Sharon Mitchell; Evrim Jaccard; Felix Michael Schmitz; Elianne von Känel; Prune Collombet; Jacques Cornuz; Gérard Waeber; Idris Guessous; Sissel Guttormsen
Journal:  BMC Med Educ       Date:  2022-07-19       Impact factor: 3.263

Review 3.  Genomics and the History of Precision Oncology.

Authors:  Deborah B Doroshow; James H Doroshow
Journal:  Surg Oncol Clin N Am       Date:  2019-10-29       Impact factor: 3.495

4.  Antibiotic Therapy in Integrated Oncology and Palliative Cancer Care: An Observational Study.

Authors:  Martine Kjølberg Moen; Erik Torbjørn Løhre; Gunnhild Jakobsen; Morten Thronæs; Pål Klepstad
Journal:  Cancers (Basel)       Date:  2022-03-22       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.